about
Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's diseaseThe alteration of sister chromatid exchange frequencies in Behçet's disease with and without HLA-B51Comorbidities of hidradenitis suppurativa (acne inversa).Immunopathogenesis of ocular Behçet's diseaseBehçet's disease (Adamantiades-Behçet's disease).The genetics of Adamantiades-Behcet's disease.Treatment of neuro-Behçet's disease: an update.Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study.Skin prick test with self-saliva in patients with oral aphthoses: a diagnostic pathergy for Behcet's disease and recurrent aphthosis.Heterotopic ossification related to toxic epidermal necrolysis in a patient with Behçet's disease.An update on Behçet's disease.A New Diagnostic Way for Behcet's Disease: Skin Prick with Self-SalivaEmerging approaches to the treatment of uveitis: patents of 2000 - 2004.Calprotectin in rheumatic diseases.Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behçet's disease-like mouse model.Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.Elevated serum levels of calprotectin (MRP8/MRP14) in patients with Behçet's disease and its association with disease activity and quality of life.Effectiveness and safety of Glycyrrhizae Decoction for Purging Stomach-Fire in Behcet disease patients: Study protocol for a randomized controlled and double-blinding trail.Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behçet's disease.SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behçet's disease.Interleukin-1-related genes polymorphisms in Turkish patients with Behçet disease: a meta-analysis.MATHEMATICAL MODELING OF BEHÇET'S DISEASE: A DYNAMICAL SYSTEMS APPROACH
P2860
Q24548765-E680F37F-01F6-4E56-AAF0-4F409FC578B9Q28294193-002DED09-4BD8-45D3-92C5-857292645F04Q33890939-79749036-A68F-453B-9C77-D98FE52B3BA8Q33908937-44E73007-85B6-4186-A2A7-A8747282A953Q34259932-5FF361D3-E5C8-44F8-B470-6CC31894BED4Q34739856-248B19B1-96AE-4198-8736-00B4A4E1D930Q34974052-37D2F17D-D191-4004-B374-8D85556013B6Q35182475-FB737E7E-68E3-4ADA-87E4-6C1233672F2AQ35585003-2B02B1A3-39EC-43F5-BE93-508745FB4473Q36207220-1014E003-B3A7-4860-BF4D-D4C44AD6EF00Q36701009-1E5C52AE-57A1-425A-A096-039B48F6F648Q37577345-129772AC-EAC8-4E3D-9135-72B39B3CAEBFQ37689191-FFE2F6F0-655C-4FED-BCC0-5339B4D0B905Q39022858-5AEFE8CB-1279-44F8-B53A-81F7D3E2977FQ45077731-950DFE09-9F22-4302-AEA5-84B19E84370AQ45227458-3BDEA638-968A-4797-ABA2-E399244655B8Q47777242-D904BD6E-7BB9-4FDD-B6F1-D05CD49EDD2DQ52622848-C3991E12-FFAC-4CC9-8010-6878B5C30518Q53280626-B14567FC-AD41-4410-A3C3-F91A24BB6731Q53407382-2F077776-A1AA-46D8-B340-05C8B0AED475Q54571731-C0BF4422-AC88-49F4-80BF-1AE09EFFEE09Q57896768-C8CEED3C-E867-47C3-8883-42515256D22B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathogenesis of Adamantiades-Behçet's disease.
@ast
Pathogenesis of Adamantiades-Behçet's disease.
@en
type
label
Pathogenesis of Adamantiades-Behçet's disease.
@ast
Pathogenesis of Adamantiades-Behçet's disease.
@en
prefLabel
Pathogenesis of Adamantiades-Behçet's disease.
@ast
Pathogenesis of Adamantiades-Behçet's disease.
@en
P1476
Pathogenesis of Adamantiades-Behçet's disease.
@en
P2093
Christos C Zouboulis
Tobias May
P2888
P304
P356
10.1007/S00430-002-0167-5
P577
2003-03-05T00:00:00Z